Health Condition 1: D279- Benign neoplasm of unspecified ovary
Conditions
Interventions
Intervention1: Study group: Laparoscopic cystectomy with vasopres-sin instillation: In the vasopressin group, 20mL of dilute vasopressin (0.05 U/ml) will be instilled in to interface between cyst wall
Sponsors
JIPMER
Eligibility
Inclusion criteria
Inclusion criteria: Women undergoing laparoscopic ovarian cystectomy for benign ovarian cysts. 1.Age 18-40 years 2.Presence of unilateral benign ovarian cyst 3.Size of the cyst between 6-15 cm
Exclusion criteria
Exclusion criteria: 1.Pregnancy 2.Active pelvic inflammatory disease (based on clinical criteria) 3.Suspected or proven genital or extra genital malignan-cy 4.Polycystic ovarian syndrome according to Rotterdam criteria Inclusion criteria: Women undergoing laparoscopic ovarian cystectomy for benign ovarian cysts. 1.Age 18-40 years 2.Presence of unilateral benign ovarian cyst 3.Size of the cyst between 6-15 cm Exclusion criteria: 1.Pregnancy 2.Active pelvic inflammatory disease (based on clinical criteria) 3.Suspected or proven genital or extra genital malignancy 4.Polycystic ovarian syndrome according to Rotterdam criteria 5.Premature menopause (cessation of menstrual periods before 40years age) 6.History of previous adnexal surgery 7. Women with cardiopulmonary diseases, bleeding diathesis and renal disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the effect of vasopressin instillation on ovarian reserve during laparoscopic ovarian cystectomy for benign ovarian cysts as measured by serum anti-mullerian hormone (AMH).Timepoint: AMH levels will checked before surgery i.e baseline and at 3rd month and 6th month post operatively | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare frequency and duration of pinpoint bipo-lar coagulation during cystectomy and complications, if any in both groups.Timepoint: one time-during surgery | — |
Countries
India
Contacts
Public ContactChitra Thyagaraju
JIPMER
Outcome results
None listed